n-(4-methoxy-1-cyclohexenyl)pyrrolidine | 52290-93-4

• 分子结构分类: 有机化合物 - 有机杂环化合物 - 吡咯烷类
• 英文名称: n-(4-methoxy-1-cyclohexenyl)pyrrolidine
• 英文别名: 4-methoxy-1-pyrrolidino-1-cyclohexene；1-(4-Methoxycyclohex-1-en-1-yl)pyrrolidine；1-(4-methoxycyclohexen-1-yl)pyrrolidine
• CAS: 52290-93-4
• 化学式: C₁₁H₁₉NO
• 分子量: 181.278
• InChiKey: IKZFNBPDKHJAJE-UHFFFAOYSA-N

计算性质

• 辛醇/水分配系数(LogP)：
  2
• 重原子数：
  13
• 可旋转键数：
  2
• 环数：
  2.0
• sp3杂化的碳原子比例：
  0.82
• 拓扑面积：
  12.5
• 氢给体数：
  0
• 氢受体数：
  2

反应信息

• 作为反应物：
  描述：

  n-(4-methoxy-1-cyclohexenyl)pyrrolidine 以 水 、 溶剂黄146 、 甲苯 为溶剂， 生成 1-(p-Hydroxyphenyl)-5-methoxy-2-phenyl-4,5,6,7-tetrahydro-indol
  参考文献：
  名称：

  1,2-Diphenyl-4,5,6,7-tetrahydroindoles

  摘要：

  这项发明涉及具有抗生育和降胆固醇活性的新型1-[4-(R.sub.1 R.sub.2 N-C.sub.n H.sub.2n -O)苯基]-5-R.sub.4 -2-(4-R.sub.3 -苯基)吲哚化合物，以及用于它们制备的新型中间体。

  公开号：

  US03968121A1

文献信息

• Method of treatment with and compositions containing condensed pyrroles
  申请人：American Hoechst Corporation

  公开号：US03931407A1

  公开（公告）日：1976-01-06

  Novel N-phenylpyrroles are disclosed that are effective in the treatment of inflammation and pain in mammals and have the formula ##SPC1## Wherein R is hydrogen, alkyl of one to six carbon atoms, thienyl, phenyl or phenyl substituted by halogen, trifluoromethyl, alkyl of one to six carbon atoms, alkoxy of one to six carbon atoms, alkanoyloxy of one to six carbon atoms, alkanoylamino of one to six carbon atoms, nitro, cyano, hydroxyl, amino or phenyl; R.sub.1 is carboxyl, alkoxycarbonyl of two to seven carbon atoms, carbamoyl, N-alkylcarbamoyl of two to seven carbon atoms, N,N-dialkylcarbamoyl of three to seven carbon atoms, hydroxycarbamoyl or dialkylphosphinylalkoxycarbonyl of four to 10 carbon atoms; R.sub.2 is hydrogen, hydroxyl, mercapto, halogen, trifluoromethyl, alkyl of one to six carbon atoms, alkoxy of one to six carbon atoms, alkanoyloxy of one to six carbon atoms, alkylthio of one to six carbon atoms, amino, alkylamino of one to six carbon atoms, dialkylamino of two to six carbon atoms, alkanoylamino of one to six carbon atoms, alkanoylthio of one to six carbon atoms, thiocarbamoyloxy, alkylthiocarbamoyloxy of two to six carbon atoms, dialkylthiocarbamoyloxy of three to seven carbon atoms, carbamoylthio, alkylcarbamoylthio of one to six carbon atoms, dialkylcarbamoylthio of two to seven carbon atoms, carbamoylamino, alkylcarbamoylamino of two to six carbon atoms or dialkylcarbamoylamino of three to seven carbon atoms; R.sub.3 is hydrogen, alkanoyl of one to six carbon atoms, or phenyl; X is alkylene of three to five carbon atoms, alkylene of three to five carbon atoms substituted by alkyl or alkoxy of one to six carbon atoms, divinylene, divinylene substituted by alkyl of one to six carbon atoms, ##SPC2## Wherein D is hydrogen, alkyl of one to six carbon atoms, alkoxy of one to six carbon atoms, alkanoyloxy of one to six carbon atoms, alkanoylamino of one to six carbon atoms, halogen, amino, nitro or trifluoromethyl; and n is 1 or 2.

  揭示了对哺乳动物的炎症和疼痛治疗有效的新型N-苯基吡咯类化合物，其化学式为##SPC1##其中R为氢、一至六个碳原子的烷基、噻吩基、苯基或被卤素、三氟甲基、一至六个碳原子的烷基、一至六个碳原子的烷氧基、一至六个碳原子的烷酰氧基、一至六个碳原子的烷酰胺基、硝基、氰基、羟基、氨基或苯基取代的苯基；R.sub.1为羧基、二至七个碳原子的烷氧羰基、氨基甲酰基、二至七个碳原子的N-烷基氨基甲酰基、三至七个碳原子的N,N-二烷基氨基甲酰基、羟基氨基甲酰基或四至十个碳原子的二烷氧羰基磷基；R.sub.2为氢、羟基、巯基、卤素、三氟甲基、一至六个碳原子的烷基、一至六个碳原子的烷氧基、一至六个碳原子的烷酰氧基、一至六个碳原子的烷硫基、氨基、一至六个碳原子的烷基氨基、二至六个碳原子的二烷基氨基、一至六个碳原子的烷酰胺基、一至六个碳原子的烷硫酰基、硫代羰氨氧基、二至六个碳原子的烷硫代羰氨氧基、三至七个碳原子的二烷硫代羰氨氧基、硫代羰氨硫基、一至六个碳原子的烷硫代羰氨硫基、二至七个碳原子的二烷硫代羰氨硫基、羰胺基、二至六个碳原子的烷羰胺基或三至七个碳原子的二烷羰胺基；R.sub.3为氢、一至六个碳原子的烷酰基或苯基；X为三至五个碳原子的烷基、被一至六个碳原子的烷基或烷氧基取代的三至五个碳原子的烷基、二烯基、被一至六个碳原子的烷基取代的二烯基，##SPC2##其中D为氢、一至六个碳原子的烷基、一至六个碳原子的烷氧基、一至六个碳原子的烷酰氧基、一至六个碳原子的烷酰胺基、卤素、氨基、硝基或三氟甲基；n为1或2。
• Substituted N-aminoalkylpyrroles
  申请人：American Hoechst Corporation

  公开号：US03997557A1

  公开（公告）日：1976-12-14

  Substituted N-aminoalkylpyrroles of the formula: ##STR1## IN WHICH X, Z, R.sub.1, -R.sub.5 and n are as defined below, and their physiologically tolerable acid addition salts are disclosed to have antiarrhythmic, central nervous system depressant, antiinflammatory and antihypertensive activity. A process for their preparation is also disclosed.

  给出的结果如下：公式为：##STR1## 其中X、Z、R.sub.1、-R.sub.5和n的定义如下，以及它们的生理耐受性酸盐被披露具有抗心律失常、中枢神经系统抑制、抗炎和降压活性。还披露了它们的制备方法。
• US3931407A
  申请人：——

  公开号：US3931407A

  公开（公告）日：1976-01-06
• US3968121A
  申请人：——

  公开号：US3968121A

  公开（公告）日：1976-07-06
• US3997557A
  申请人：——

  公开号：US3997557A

  公开（公告）日：1976-12-14